Percheron Therapeutics LimitedASX: PER

ATL1102 Toxicology Protocol submitted to US FDA

Dec 9, 2021 at 4:09 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment